Jeremy Skillington, PhD, CEO of Poolbeg Pharma, discusses the results from the proposal to purchase shares from Distribution in Specie Shareholders.
Poolbeg Pharma is a clinical-stage infectious disease pharmaceutical company with a unique capital-light clinical model.
Industry: Health Care
Contact: +44 207 183 1499 New Road https://www.poolbegpharma.com/